40912-34-3

Basic information

• Product Name: 3-(1-hydroxy-1-methylethyl)benzoic acid
• Synonyms: 3-(1-hydroxy-1-methylethyl)benzoic acid
• CAS NO: 40912-34-3
• Molecular Weight: 180.203
• Mol File: 40912-34-3.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 3-(1-hydroxy-1-methylethyl)benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(1-hydroxy-1-methylethyl)benzoic acid(40912-34-3)
• EPA Substance Registry System: 3-(1-hydroxy-1-methylethyl)benzoic acid(40912-34-3)

Safety Data

• Hazardous Substances Data: 40912-34-3(Hazardous Substances Data)

Upstream product

• 535-77-3 m-cymene 
• 586-42-5 3-acetylbenzoic acid 
• 75-16-1 methylmagnesium bromide 
• 585-76-2 m-bromobenzoic acid 
• 67-64-1 acetone 
• 37847-24-8 3-acetyl-benzoic acid ethyl ester 
• 5208-37-7 8-hydroxy-m-cymene 

Downstream Products

• 61776-64-5 3-(α-chloro-isopropyl)-benzoic acid 
• 105640-23-1 ethyl 3-isopropenylbenzoate 
• 61776-63-4 3-(α-chloro-isopropyl)-benzoic acid methyl ester 
• 1346690-08-1 2-[3-(hydroxymethyl)phenyl]propan-2-ol 
• 136279-23-7 2-[3-(bromomethyl)phenyl]propan-2-ol 
• 1418295-66-5 3-{(Z)-1-fluoro-2-[4-(1,1,1-trifluoro-2-methylpropan-2-yl)phenyl]vinyl}-5-methyl-1-[3-(prop-1-en-2-yl)benzyl]-1H-pyrazole 
• 1418296-15-7 2-{3-[(3-{(Z)-1-fluoro-2-[4-(1,1,1-trifluoro-2-methylpropan-2-yl)phenyl]vinyl}-5-methyl-1H-pyrazol-1-yl)methyl]phenyl}propan-2-ol 
• 1448316-74-2 N-{2,4-dimethyl-5-[6-(pyridin-3-yl)-1H-imidazo[1,2-b]pyrazol-1-yl]phenyl}-3-(2-hydroxypropan-2-yl)benzamide 

Relevant articles and documents

COMPOUNDS AND USES THEREOF

The present disclosure features compounds useful for the treatment of BAF complex-related disorders.

BISAMIDE SARCOMERE ACTIVATING COMPOUNDS AND USES THEREOF

The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising a compound of the invention, a method for manufacturing compounds of the invention and therapeutic uses thereof.

Substituted phenylimidazopyrazoles and their use

The present application relates to novel 1-phenyl-1H-imidazo[1,2-b]pyrazole derivatives, to processes for their preparation, to their use for the treatment and/or prevention of diseases and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular angiogenic disorders and hyperproliferative disorders, where neovascularization plays a role, such as, for example, neoplastic disorders and tumour disorders. Such treatments can be carried out as monotherapy or else in combination with other medicaments or further therapeutic measures.